Product I3525, Recombinant Human IL-17A, was lyophilized with no additives, which means it was lyophilized from water and may contain trace amounts of 0.1% TFA (pH 2.0) from being HPLC-purified.
I3525
Interleukin-17A human
≥98% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Synonym(s):
CTLA-8, IL-17
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Size/SKU | Availability | Price |
|---|---|---|
50 μg | Please contact Customer Service for Availability | PLN 3,210.00 |
About This Item
PLN 3,210.00
Please contact Customer Service for Availability
biological source
human
Quality Segment
recombinant
expressed in E. coli
assay
≥98% (SDS-PAGE)
form
lyophilized powder
potency
≤2.0 ng/mL ED50
mol wt
31 kDa
packaging
pkg of 50 μg
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested (endotoxin level is less than 0.1 ng per μg cytokine (1 EU/μg).)
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... IL17A(3605)
Biochem/physiol Actions
IL-17, initially known as CTLA-8, is a T cell-expressed polypeptide that appears to be involved in the regulation of the hematopoietic system. IL-17 has been shown to induce IL-6, IL-8, and G-CSF production by fibroblasts; all of these cytokines have demonstrated effects on hematopoiesis.
Initially known as CTLA-8; is a T cell-expressed polypeptide that appears to be involved in the regulation of the hematopoietic system; has been shown to induce IL-6, IL-8, and G-CSF production by fibroblasts; all of these cytokines have demonstrated effects on hematopoiesis.
Physical form
Lyophilized with no additives.
Analysis Note
- The biological activity of human IL-17 is measured by its ability to induce IL-6 production using NHDF cells.
- Biological activity is also determined by the dose-dependent induction of IL-6 in primary human foreskin fibroblast. The expected ED50 is < 2.0 ng/ml, corresponding to a specific activity of > 5 x 105 units/mg.
1 of 1
This Item | |||
|---|---|---|---|
| technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable |
| assay ≥98% (SDS-PAGE) | assay ≥97% (SDS-PAGE) | assay ≥98% (HPLC), ≥98% (SDS-PAGE) | assay ≥98% (SDS-PAGE) |
| biological source human | biological source mouse | biological source human | biological source human |
| recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in E. coli |
| Quality Level 100 | Quality Level 200 | Quality Level - | Quality Level 200 |
| form lyophilized powder | form lyophilized powder | form lyophilized | form lyophilized powder |
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
-
What is the solution from which product I3525, Interleukin-17A human recombinant, was prepared?
1 answer-
Helpful?
-
-
What is the Department of Transportation shipping information for this product?
1 answer-
Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.
Helpful?
-